Dementia drug neflamapimod shows positive phase 2b trial results - PharmaTimes CervoMed's therapy demonstrates significant improvement in patients

#AlzheimersDisease #Dementia #neflamapimod #CNSdisorders #biotech #CervoMed #dementiapatients #RewinDLBstudy #dementiawithLewybodies #DLB #ClinicalDementiaRatingSumofBoxes #CDRSB #AlzheimersDiseaseCooperativeStudy #ClinicalGlobalImpressionofChange #CGIC
pharmatimes.com/news/dementi...